Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Change in Acquisitions & Divestments: 2016-2025

Historic Change in Acquisitions & Divestments for Heron Therapeutics (HRTX) over the last 8 years, with Sep 2025 value amounting to $18.0 million.

  • Heron Therapeutics' Change in Acquisitions & Divestments fell 40.24% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.3 million, marking a year-over-year decrease of 25.97%. This contributed to the annual value of $123.5 million for FY2024, which is 15.20% up from last year.
  • Latest data reveals that Heron Therapeutics reported Change in Acquisitions & Divestments of $18.0 million as of Q3 2025, which was up 7.42% from $16.7 million recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Change in Acquisitions & Divestments registered a high of $58.0 million during Q2 2021, and its lowest value of $13.5 million during Q3 2023.
  • Over the past 3 years, Heron Therapeutics' median Change in Acquisitions & Divestments value was $25.2 million (recorded in 2025), while the average stood at $26.4 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first plummeted by 86.17% in 2021, then soared by 122.56% in 2024.
  • Over the past 5 years, Heron Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $14.0 million in 2021, then surged by 50.00% to $21.0 million in 2022, then declined by 29.76% to $14.8 million in 2023, then spiked by 65.23% to $24.4 million in 2024, then plummeted by 40.24% to $18.0 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $18.0 million for Q3 2025, versus $16.7 million for Q2 2025 and $25.2 million for Q1 2025.